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Differential Phenotypes in Perivascular Adipose Tissue Surrounding
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Yosuke Kuroda, MD, PhD; Ryo Harada, MD, PhD; Toshiro Ito, MD, PhD; Yukimura Higashiura, MD; Masayuki Koyama, MD, PhD;
Marenao Tanaka, MD, PhD; Norihito Moniwa, MD, PhD; Masanori Nakamura, MD, PhD; Hirosato Doi, MD; Tetsuji Miura, MD, PhD;
Nobuyoshi Kawaharada, MD, PhD
Background-—Perivascular adipose tissue (PVAT) is causally associated with vascular function and the pathogenesis of vascular
disease in association with metabolically driven chronic inflammation called metaflammation. However, the difference in PVAT
surrounding the coronary artery (CA-PVAT) and that surrounding the internal thoracic artery (ITA-PVAT), a vessel resistant to
atherosclerosis, remains unclear. Herein, we investigated whether CA-PVAT, ITA-PVAT, and subcutaneous adipose tissue (SCAT)
have distinct phenotypes.
Methods and Results-—Fat pads were sampled from 44 patients (men/women, 36:8; age, 6713 years) with CA disease who
underwent elective CA bypass grafting. Adipocyte size in ITA-PVAT and that in CA-PVAT were significantly smaller than that in
SCAT. A greater extent of fibrosis and increased gene expression levels of fibrosis-related molecules were observed in CA-PVAT
than those in SCAT and those in ITA-PVAT. CA-PVAT exhibited more pronounced metaflammation, as indicated by a significantly
larger extent of CD68-positive and CD11c-positive M1 macrophages, a lower ratio of CD206-positive M2 to CD11c-positive M1
macrophages, a lower gene expression level of adiponectin, and higher gene expression levels of inflammatory cytokines and
inflammasome- and endoplasmic reticulum stress–related molecules, than did ITA-PVAT and SCAT. Expression patterns of
adipocyte developmental and pattern-forming genes were totally different among SCAT, ITA-PVAT, and CA-PVAT.
Conclusions-—The phenotype of ITA-PVAT is closer to that of SCAT than that of CA-PVAT, which may result from inherent
differences in adipocytes. ITA-PVAT appears to be protected from metaflammation and consecutive adipose tissue remodeling,
which may contribute to the decreased atherosclerotic plaque burden in the ITA. ( J Am Heart Assoc. 2019;8:e011147. DOI: 10.
1161/JAHA.118.011147)
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O besity is a risk factor for atherosclerotic cardiovasculardisease.1 Accumulation of visceral adipose tissue in obesity
promotes a state of metabolically driven chronic and low-grade
inflammation called metaflammation, which is characterized by
abnormal adipokine production andactivationof proinflammatory
pathways.2 Several bioactive molecules derived from adipose
tissue, adipokines, have been implicated in the increased risk of
atherosclerotic cardiovascular disease.1,2 Adiponectin, a favor-
able adipokine, has been shown to modulate macrophage
function in the direction of an anti-inflammatory phenotype.3
Adiponectin directly increases insulin sensitivity and protects
against initiation and progression of atherosclerosis. Conversely,
induction of several chemokines and cytokines as adipokines and
activation of inflammasomes and endoplasmic reticulum stress
have been reported to be associated with obesity-induced insulin
resistance and atherosclerosis.1,2,4–6
Adipose tissue in obesity is characterized by adipocyte
hypertrophy, followed by immune cell infiltration, overproduction
From the Department of Cardiovascular Surgery (R.N., H.S., Y.Y., Y.K., R.H., T.I., H.D., N.K.), and Cardiovascular, Renal and Metabolic Medicine (M.F., M.M., Y.H., M.K.,
M.T., N.M., T.M.), Sapporo Medical University School of Medicine, Sapporo, Japan; Department of Cardiovascular Surgery, Sapporo City General Hospital, Sapporo,
Japan (M.N.); and Department of Cardiovascular Surgery, Sapporo Cardiovascular Clinic, Sapporo, Japan (H.D.).
*Dr Numaguchi and Dr Furuhashi contributed equally to this work.
Correspondence to: Masato Furuhashi, MD, PhD, Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine,
S-1, W-16, Chuo-ku, Sapporo 060-8543, Japan. E-mail: furuhasi@sapmed.ac.jp
Received October 4, 2018; accepted December 12, 2018.
ª 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons
Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for
commercial purposes.





 http://ahajournals.org by on January 14, 2019
of extracellular matrix, and increased angiogenesis, a process
that is referred to as adipose tissue remodeling.7–9 Obesity
induces infiltration of adipose tissue macrophages, which are
characteristic of classically activatedM1macrophages, whereas
resident macrophages in adipose tissue are alternatively
activated M2 macrophages.10 A shift to the activated M1-
polarized state of adipose tissue macrophages from an M2-
polarized state has been reported to contribute to metaflamma-
tion and insulin resistance.10,11
Perivascular adipose tissue (PVAT) has traditionally been
thought to play a role in supporting vascular structure and
metabolism. PVAT has recently been proposed to influence
vascular function and the pathogenesis of vascular disease.12
PVAT is implicated in the regulation of vascular tone by releasing
adipose-derived relaxing and contracting factors, which con-
tribute to the protection and progression of atherosclerotic
vascular disease.13–16 It has also been reported that chronic
inflammation in the coronary adventitia and PVAT is associated
with the pathogenesis of vasospastic angina.17 Furthermore,
epicardial fat may directly influence coronary atherogenesis and
myocardial function because there is no fibrous fascial layer to
impede diffusion of free fatty acids and adipokines from the fat
underlying the myocardium and vessels.18 It has been reported
that epicardial adipose tissue is a source of inflammatory
mediators.19 Furthermore, an elevated volumeof PVATunderlying
thecoronary artery (CA)was shown tobe strongly associatedwith
coronary atherosclerosis in combination with an imbalance of
cytokines and adipokines.20–22
The internal thoracic artery (ITA) is protected from the
development of atherosclerosis,23 although the reasons are still
largely unknown. The ITA is frequently used as the gold standard
graft material for CA bypass grafting (CABG) because of its
excellent long-term patency.24 It has been reported that the ITA
has less concentric atheromatous intimal thickening involving the
whole circumference than does the right gastroepiploic artery, a
candidate of graft vessels for CABG, even in patients with several
coronary risk factors.25 As another possible mechanism of the
long-term patency of the ITA, excellent endothelial function,
including shear stress sensing and generation of NO and
antithrombotic factors, of the ITA has been reported to provide
physiological andmetabolic effects that are beneficial in both the
graft and recipient CA.23,24 However, the association of PVATwith
vascular structure and function of the ITA and CA is not well
understood. In the present study, we investigated the differential
phenotype of fat pads on the structure and gene expression in
PVATsurrounding the ITA (ITA-PVAT) andCA (CA-PVAT) in patients
with CA disease who underwent elective CABG.
Methods
The data that support the findings of this study are available
from the corresponding author on reasonable request.
Study Patients
Patients diagnosed with CA disease who underwent elective
CABG surgery were recruited from Sapporo Medical University
Hospital and the affiliated Sapporo Cardiovascular Clinic and
Sapporo City General Hospital from May 2017 through March
2018. Patients treated with hemodialysis and those who
underwent CABG without using the ITA were excluded. This
study conformed to the principles outlined in the Declaration
of Helsinki and was performed with the approval of the Ethical
Committee of Sapporo Medical University. Written informed
consent was received from all of the study subjects.
Collection of Fat Pads
Fat pads of subcutaneous adipose tissue (SCAT) from beneath
the skin of the upper abdomen near the sternum, ITA-PVAT
from the area of the left ITA, and CA-PVAT from the area of the
left CA were collected during surgery before anticoagulation
and establishment of extracorporeal circulation. The samples
were divided into 2 parts. The first specimen was stored in
formalin and embedded in paraffin for histological staining.
The second specimen was frozen in liquid nitrogen for further
mRNA isolation and real-time polymerase chain reaction.
Clinical Perspective
What Is New?
• Augmented immune cell infiltration, induction of inflamma-
tory cytokines, activation of inflammasomes and endoplas-
mic reticulum stress, and increased fibrosis were observed
in perivascular adipose tissue (PVAT) surrounding the
coronary artery compared with that surrounding the internal
thoracic artery (ITA-PVAT) and subcutaneous adipose tissue
of patients who underwent elective coronary artery bypass
grafting surgery.
• Expression patterns of adipocyte developmental and pat-
tern-forming genes were totally different among subcuta-
neous adipose tissue, ITA-PVAT, and PVAT surrounding the
coronary artery.
• The phenotype of ITA-PVAT was closer to that of subcuta-
neous adipose tissue than that of PVAT surrounding the
coronary artery, which may result from inherent differences
in adipocytes.
What Are the Clinical Implications?
• Protection from metaflammation and consecutive adipose
tissue remodeling in ITA-PVAT may contribute to the
decreased atherosclerotic plaque burden in the ITA, an
atherosclerosis-resistant vessel.
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Histological Analysis
Samples of fat pads were fixed in 10% formalin solution,
dehydrated, and embedded in paraffin. Serial 5-lm sections
were cut, mounted onto glass slides, deparaffinized, and
rehydrated through degraded ethanol. Tissues were stained
with hematoxylin-eosin and Masson’s trichrome reagents.
Immunohistochemical staining using mouse anti-CD68
(Dako, Santa Clara, CA), rabbit anti-CD11c (Abcam, Cam-
bridge, UK), also known as integrin a X chain, and mouse anti-
CD206 (Abnova, Taipei, Taiwan), also known as mannose
receptor C-type 1, antibodies was performed as previously
described.26,27 Control experiments were performed by
omitting the primary antibodies.
Quantitative Image Analysis
Imageswere capturedwith amicroscope (BIOREVOBZ-9000with
a BZ-II analyzer; Keyence, Osaka, Japan). Image analyses were
performed using ImageJ and Fiji software. The cross-sectional
area of an adipocyte in hematoxylin-eosin staining was deter-
mined by calculating the mean area of 200 randomly selected
adipocytes per optical field at 9200 magnification. The results
were averaged, and they are expressed as adipocyte size (lm2).
After checking sections of hematoxylin-eosin staining to avoid
nonspecific fibrosis staining in the adventitia, sections were
chosen to stain the fibrosis area in the inside, but not the edge, of
adipose tissue from19consecutive patients, forwhomsections in
a set of 3 parts of adipose tissue were all adequate. Fibrosis was
assessed on Masson’s trichrome-stained tissue sections by
quantifying the blue area representing collagen relative to the
total tissue area at9100 magnification. In 10 of the 19 patients,
macrophage infiltration in tissue sections was assessed by
quantifying the brown area stained by anti-CD68, anti-CD11c, or
anti-CD206 antibodies relative to the total tissue area at 9100
magnification. For each quantitative analysis of fibrosis and
macrophage infiltration, 3 randomly selected optical fields were
examined per adipose tissue depot, and the results were
averaged. Results are expressed as percentage positive area
per total area. All of the measurements were performed in a
double-blind manner by 2 different researchers (R.N., M.F.).
Quantitative Real-Time Polymerase Chain
Reaction
Total RNA was isolated from samples in a set of 3 fat pads
(n=27 each group) using the miRNeasy Micro Kit (Qiagen,
Hilden, Germany). The amount and quality of isolated RNA
were determined spectrophotometrically using Nanodrop
(Thermo Fisher Scientific, Waltham, MA), and 500 ng of total
RNA was reverse transcribed by using the high-capacity cDNA
archive kit Reverse Transcription Kit (Applied Biosystems,
Foster City, CA). Quantitative real-time polymerase chain
reaction analysis was performed using SYBR Green in the real-
time polymerase chain reaction system (Applied Biosystems,
Warrington, UK). The thermal cycling program was 10 min-
utes at 95°C for enzyme activation and 40 cycles of
denaturation for 15 s at 95°C, 30-s annealing at 58°C, and
30-s extension at 72°C. Primers used in the present study are
listed in Table 1. To normalize expression data, 18s rRNA was
used as an internal control gene.
Statistical Analysis
Numeric variables are expressed as meanSD or meanSEM
for normal distributions or median (interquartile range) for
skewed variables. Mixed model analysis was used for
detecting significant differences in repeated measures data
between SCAT, ITA-PVAT, and CA-PVAT. P<0.05 was consid-
ered statistically significant. All data were analyzed by using
JMP for Macintosh (SAS Institute, Cary, NC).
Results
Basal Characteristics of the Studied Patients
Basal characteristics of the 44 recruited patients (men/
women, 36:8) who underwent elective CABG surgery using
the ITA are shown in Table 2. Age and body mass index of the
recruited patients were 6713 years and 24.44.1 kg/m2,
respectively. Most of the patients (95.5%) were diagnosed
with multivessel CA disease. The numbers of patients with
diabetes mellitus, hypertension, dyslipidemia, and myocardial
infarction were 18 (40.9%), 31 (70.5%), 34 (77.3%), and 13
(29.5%), respectively. The ejection fraction assessed by
echocardiography was 6112%. Data for laboratory mea-
surements are shown in Table 3.
Adipocyte Size in Fat Pads
Representative hematoxylin-eosin staining of SCAT, ITA-PVAT,
and CA-PVAT is shown in Figure 1A. Adipocyte size in ITA-
PVAT and that in CA-PVAT were significantly smaller than that
in SCAT (Figure 1B). There was no significant difference in
adipocyte size between ITA-PVAT and CA-PVAT. Crownlike
structures, which have been reported to be composed of
macrophages surrounding dead or dying adipocytes,28 were
observed in CA-PVAT but not in SCAT or ITA-PVAT.
Fibrosis in Fat Pads
Representative Masson’s trichrome staining of SCAT, ITA-
PVAT, and CA-PVAT is shown in Figure 2A. The fibrosis area in
the inside, but not the edge, of adipose tissue in ITA-PVAT and
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that in CA-PVAT were significantly larger than that in SCAT
(Figure 2B). CA-PVAT had a significantly larger fibrosis area
than did ITA-PVAT (Figure 2B). ITA-PVAT and CA-PVAT had
significantly higher gene expressions of fibrosis-related
molecules, transforming growth factor-b, and macrophage-
inducible C-type lectin (MINCLE), also known as C-type lectin
domain family 4 member E, than did SCAT; and gene
expression levels of transforming growth factor-b and MINCLE
in CA-PVAT were significantly higher than those in ITA-PVAT
(Figure 2C). Gene expression levels of other fibrosis-related
molecules, including tissue inhibitor of metalloproteinase 1,
platelet-derived growth factor subunit B, and collagen type 6 a
1 chain, in CA-PVAT were significantly higher than those in
SCAT and those in ITA-PVAT (Figure 2C).
Macrophage Infiltration in Fat Pads
Representative immunohistological staining, including CD68,
a marker of macrophages, CD11c, a marker of M1
macrophages, and CD206, a marker of M2 macrophages, of
SCAT, ITA-PVAT, and CA-PVAT is shown in Figure 3A. The
macrophage infiltration area stained by anti-CD68 antibody in
ITA-PVAT and that in CA-PVAT were significantly larger than
that in SCAT (Figure 3B). The inflammatory area of M1
phenotype of macrophage infiltration stained by anti-CD11c
antibody in CA-PVAT was significantly larger than that in SCAT
and that in ITA-PVAT (Figure 3C). The area of M2 phenotype of
macrophage infiltration stained by anti-CD206 antibody in
ITA-PVAT and that in CA-PVAT were significantly larger than
that in SCAT (Figure 3D). The ratio of CD206-positive to
CD11c-positive macrophages in CA-PVAT was significantly
lower than that in SCAT and that in ITA-PVAT (Figure 3E).
Metaflammation in Fat Pads
Gene expression levels of monocyte chemoattractant protein-
1, a chemokine, and inflammatory cytokines, including
interleukin-1b, interleukin-6, and tumor necrosis factor-a, in
CA-PVAT were significantly higher than those in SCAT and
those in ITA-PVAT (Figure 4A). Gene expression levels of M2
macrophage markers, CD163 and CD206, in ITA-PVAT and
those in CA-PVAT were significantly higher than those in SCAT
(Figure 4B). The gene expression level of interleukin-10, an
anti-inflammatory cytokine as an M2 macrophage-related
marker, in ITA-PVAT, but not that in CA-PVAT, was significantly
higher than that in SCAT (Figure 4B).
Table 1. Primers for Human Genes in Quantitative Real-Time PCR
Genes Accession No. Forward Primer Reverse Primer
18s M10098 50-GTAACCCGTTGAACCCCATT-30 50-CCATCCAATCGGTAGTAGCG-30
Adiponectin NM_004797 50-GGCATGACCAGGAAACCAC-30 50-TTCACCGATGTCTCCCTTAGG-30
Asc NM_145182 50-TGGATGCTCTGTACGGGAAG-30 50-CCAGGCTGGTGTGAAACTGAA-30
Cd163 NM_004244 50-GCGGGAGAGTGGAAGTGAAAG-30 50-GTTACAAATCACAGAGACCGCT-30
Cd206 NM_002438 50-GGGTTGCTATCACTCTCTATGC-30 50-TTTCTTGTCTGTTGCCGTAGTT-30
Chop NM_004083 50-GGAGAACCAGGAAACGGAAAC-30 50-TCTCCTTCATGCGCTGCTTT-30
Col6a1 NM_001848 50-ACAGTGACGAGGTGGAGATCA-30 50-GATAGCGCAGTCGGTGTAGG-30
Emx2 NM_004098 50-CGGCACTCAGCTACGCTAAC-30 50-CAAGTCCGGGTTGGAGTAGAC-30
En1 NM_001426 50-GAGCGCAGGGCACCAAATA-30 50-CGAGTCAGTTTTGACCACGG-30
Grp78 NM_005347 50-CATCACGCCGTCCTATGTCG-30 50-CGTCAAAGACCGTGTTCTCG-30
Hoxa5 NM_019102 50-AACTCATTTTGCGGTCGCTAT-30 50-TCCCTGAATTGCTCGCTCAC-30
Il1b NM_000576 50-CACGATGCACCTGTACGATCA-30 50-GTTGCTCCATATCCTGTCCCT-30
Il6 NM_000600 50-AAATTCGGTACATCCTCGACGG-30 50-GGAAGGTTCAGGTTGTTTTCTGC-30
Il10 NM_000572 50-GACTTTAAGGGTTACCTGGGTTG-30 50-TCACATGCGCCTTGATGTCTG-30
Mcp1 NM_002982 50-CAGCCAGATGCAATCAATGCC-30 50-TGGAATCCTGAACCCACTTCT-30
Mincle NM_014358 50-CTGAAACACAATGCACAGAGAGA-30 50-AAAGATGCGAAATGTCACAACAC-30
Nlrp3 NM_001127462 50-GATCTTCGCTGCGATCAACAG-30 50-CGTGCATTATCTGAACCCCAC-30
Pdgfb NM_033016.2 50-CTCGATCCGCTCCTTTGATGA-30 50-CGTTGGTGCGGTCTATGAG-30
Tgfb NM_000660 50-CAAGCAGAGTACACACAGCAT-30 50-TGCTCCACTTTTAACTTGAGCC-30
Timp1 NM_003254 50-CTTCTGCAATTCCGACCTCGT-30 50-ACGCTGGTATAAGGTGGTCTG-30
Tnfa NM_000594 50-GAGGCCAAGCCCTGGTATG-30 50-CGGGCCGATTGATCTCAGC-30
PCR indicates polymerase chain reaction.
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The gene expression level of adiponectin, an adipokine with
antiatherogenic and anti-inflammatory features, in CA-PVAT
was significantly lower than that in SCAT and that in ITA-PVAT
(Figure 4C), whereas gene expression levels of inflammasome-
related molecules, including nucleotide-binding domain, leu-
cine-rich–containing family, pyrin domain–containing-3 and
apoptosis-associated specklike protein containing caspase
recruitment domain, and endoplasmic reticulum stress-related
molecules, including glucose-regulated protein 78 and C/EBP
homologous protein, in CA-PVAT were significantly higher than
those in SCAT and those in ITA-PVAT (Figure 4C).
Adipocyte Developmental and Pattern-Forming
Genes in Fat Pads
To address phenotypic differences in 3 parts of adipose
tissue, gene expression levels of adipocyte developmental and
pattern-forming genes, as previously indicated,29–31 including
engrailed homeobox 1, empty spiracles homeobox 2, and
homeobox A5, were investigated (Figure 4D). ITA-PVAT had
significantly lower gene expression levels of engrailed home-
obox 1 and empty spiracles homeobox 2 and higher gene
expression level of homeobox A5 than did SCAT, whereas CA-
PVAT had a significantly lower gene expression level of
engrailed homeobox 1 than did SCAT. Expression patterns of
these developmental and pattern-forming genes were totally
different among SCAT, ITA-PVAT, and CA-PVAT.
Discussion
The present study demonstrated pronounced metaflammation
and consecutive adipose tissue remodeling (namely, aug-
mented immune cell infiltration, induction of inflammatory
cytokines, activation of inflammasomes and endoplasmic
reticulum stress, and increased fibrosis) in CA-PVAT com-
pared with those in ITA-PVAT and SCAT of patients who
underwent elective CABG surgery. The phenotypic difference
of metaflammation in CA-PVAT might be linked to suscepti-
bility of the CA surrounded by epicardial fat to atherosclero-
sis. The phenotype of ITA-PVAT was closer to that of SCAT
than that of CA-PVAT. Protection from metaflammation in ITA-
Table 3. Laboratory Measurements
Variable Value
Hemoglobin, g/dL 12.82.0
AST, IU/L 28 (22–36)
ALT, IU/L 23 (16–38)
cGTP, IU/L 27 (20–44)
Blood urea nitrogen, mg/dL 17 (13–22)
Creatinine, mg/dL 0.91 (0.79–1.07)
eGFR, mL/min per 1.73 m2 62.016.9
Uric acid, g/dL 6.21.4
Total cholesterol, mg/dL 15938
LDL cholesterol, mg/dL 8835
HDL cholesterol, mg/dL 4711
Triglycerides, mg/dL 115 (71–137)
Fasting glucose, mg/dL 100 (90–117)
Insulin, lU/mL 2.3 (1.0–5.5)
HOMA-R 0.54 (0.28–1.34)
HbA1c, % 6.10.9
NT-proBNP, pg/mL 162 (40–277)
Variables are expressed as meanSD or median (interquartile range). ALT indicates
alanine transaminase; AST, aspartate transaminase; eGFR, estimated glomerular
filtration rate; cGTP, c-glutamyl transpeptidase; HbA1c, hemoglobin A1c; HDL, high-
density lipoprotein; HOMA-R, homeostasis model assessment of insulin resistance; LDL,
low-density lipoprotein; NT-proBNP, N-terminal pro-B-type natriuretic peptide.
Table 2. Characteristics of the Recruited Patients
Characteristics Value
No. (men/women) 44 (36:8)
Age, y 6713
Body mass index, kg/m2 24.44.1
Systolic blood pressure, mm Hg 12515
Diastolic blood pressure, mm Hg 7214
Pulse rate, bpm 7415
Coronary artery disease
1-Vessel disease 2 (4.5)
2-Vessel disease 13 (29.5)
3-Vessel disease 29 (65.9)
Complications
Diabetes mellitus 18 (40.9)
Hypertension 31 (70.5)
Dyslipidemia 34 (77.3)
Myocardial infarction 13 (29.5)
Medications
Oral antidiabetic drugs 11 (25.0)
Insulin 5 (11.4)
ACEI or ARB 19 (43.2)
b Blocker 20 (45.5)
Statin 31 (70.5)
Antiplatelet drugs 38 (86.4)
Echocardiography
Ejection fraction, % 6112
Variables are expressed as number (percentage) or meanSD. ACEI indicates
angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; bpm, beats
per minute.
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PVAT may contribute to the decreased atherosclerotic plaque
burden in the ITA. Furthermore, a differential expression
pattern of adipocyte developmental and pattern-forming
genes, as previously indicated,29–31 was observed in distinct
adipose tissue, suggesting that fat depot–specific features
result from inherent differences in adipocytes. To the best of
our knowledge, this is the first study in which the differential
phenotype of metaflammation in fat pads surrounding the ITA,
an atherosclerosis-resistant vessel, was investigated in com-
parison to that surrounding the CA.
Epicardial fat shares a common embryological origin with
mesenteric and omental fat, and the origin is the splanchno-
pleuric mesoderm associated with the gut.32 Anatomically
separated regional adipose depots have also been shown to be
distinct with respect to gene expression patterns and functional
characteristics.29–31 It has been reported that in vitro differen-
tiation of preadipocytes isolated from regional adipose depots
produces adipocytes that phenotypically resemble in vivo coun-
terparts of adipocytes.29–31,33 Phenotypic differences in adipo-
cytes can stem fromdevelopmental divergenceof precursor cells
in distinct adipose tissue. In the present study, the expression
patterns of adipocyte developmental and pattern-forming genes,
as previously indicated,29–31 including engrailed homeobox 1,
empty spiracles homeobox 2, and homeobox A5, were totally
different among SCAT, ITA-PVAT, and CA-PVAT. Fat pads from
ITA-PVAT andCA-PVAT exhibited unique geneexpression profiles
that underlie their roles in vascular homeostasis. These findings
are consistent with the notion that adipocytes residing in these
depots are derived from distinct precursor cells, which may
underlie the phenotypic differences, although immune cells in
adipose tissue may have some effects.
The ITA arises from the subclavian artery and exists in a stable
retrosternal position. On the other hand, the CA kinks and twists
on every heartbeat, and the internal lamina of the CA is constantly
experiencing tissue friction and exhaustion, which subsequently
allows the migration of cells and infiltration of plasma contents,
resulting in accelerated progression of atherosclerosis of the
artery, particularly in patients with hyperlipidemia and/or
diabetes mellitus.34,35 Mechanical stress as well as metabolic
stress may cause genetic and epigenetic changes of several
inflammatory genes, leading to more pronounced metaflamma-
tion in CA-PVAT compared with that in ITA-PVAT, especially in
patients complicated with metabolic diseases, including obesity,
diabetes mellitus, dyslipidemia, and hypertension.
Segments of coronary arteries lacking epicardial fat or
separated from epicardial fat by a bridge of myocardial tissue
have been reported to be protected against the development of
atherosclerosis.36,37 On the other hand, the development of PVAT
Figure 1. Adipocyte size in fat pads. A, Representative hematoxylin-eosin (H-E) staining of subcutaneous
adipose tissue (SCAT) and of perivascular adipose tissue surrounding the internal thoracic artery (ITA-PVAT)
and that surrounding the coronary artery (CA-PVAT). Bar=100 lm. B, Comparison of adipocyte sizes in
SCAT, ITA-PVAT, and CA-PVAT (n=44 in each group). Results are shown as meanSD. *P<0.05 vs SCAT.
DOI: 10.1161/JAHA.118.011147 Journal of the American Heart Association 6
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has been reported to be reduced and impaired with increased
inflammation in the experimental models of atherosclerosis,38,39
suggesting that the lack of normal PVAT is sufficient to drive
increased atherosclerosis. Autopsy analyses demonstrated that
there wasmoremacrophage infiltration in epicardial fat in vessels
with large necrotic core plaques than in vessels without lipid core
plaques.18,40 It has also been reported that artery tertiary
lymphoid organs in the adventitial connective tissue surrounding
arteries control atherosclerosis immune responses and protect
against atherosclerosis via vascular smooth muscle cell lympho-
toxinb receptor signaling.41 In thepresent study, patientswithout
CA disease were not included as a control group. Therefore, it is
difficult to determinewhether the inflammatory response in PVAT
is the cause or the result of atherosclerosis. Mechanistic studies
are needed to clarify what underlies the relationship between the
development of atherosclerosis and differential phenotypes of
PVAT. In addition, the association of ITA-PVAT with other factors
that may affect resistance of the ITA to atherosclerosis, including
shear stress,23,24 endothelium-dependent vasodilatation,24,42
and the difference in gene expression levels of proatherogenic
and antiatherogenic proteins in endothelial cells,43,44 also needs
to be clarified.
Figure 2. Fibrosis in fat pads. A, Representative Masson’s trichrome staining of subcutaneous adipose
tissue (SCAT) and of perivascular adipose tissue surrounding the internal thoracic artery (ITA-PVAT) and that
surrounding the coronary artery (CA-PVAT). Bar=200 lm. B, Fibrosis areas in SCAT, ITA-PVAT, and CA-PVAT
(n=19 in each group). Results are shown as meanSD. C, Gene expression levels of fibrosis-related
molecules, including transforming growth factor-b (TGF-b), tissue inhibitor of metalloproteinase 1 (TIMP1),
platelet-derived growth factor subunit B (PDGFB), collagen type 6 a 1 chain (COL6a1), and macrophage-
inducible C-type lectin (MINCLE), in SCAT, ITA-PVAT, and CA-PVAT (n=27 in each group). Results are shown
as relative expression of each target gene in SCAT of each patient and as meanSEM. AU indicates
arbitrary unit. *P<0.05 vs SCAT; †P<0.05 vs ITA-PVAT.
DOI: 10.1161/JAHA.118.011147 Journal of the American Heart Association 7
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Adipose tissue fibrosis is thought to limit the expandability
of adipose tissue during the development of obesity, leading
to ectopic fat accumulation in nonadipose tissue, such as the
liver and skeletal muscle.8,9,45 In fact, adipose tissue fibrosis
has been reported to be negatively correlated with adipocyte
size in human adipose tissue.46 It has recently been reported
that MINCLE is mainly localized to proinflammatory M1
macrophages in crownlike structures of adipose tissue47 and
Figure 3. Macrophage infiltration in fat pads. A, Representative immunohistological staining, including
CD68 (a marker of macrophages), CD11c (a marker of M1 macrophages), and CD206 (a marker of M2
macrophages), of subcutaneous adipose tissue (SCAT) and of perivascular adipose tissue surrounding the
internal thoracic artery (ITA-PVAT) and that surrounding the coronary artery (CA-PVAT). Bar=50 lm. B
through D, Positive areas of immunohistological staining of CD68, CD11c, and CD206 in SCAT, ITA-PVAT,
and CA-PVAT (n=10 in each group). E, Ratios of the macrophage infiltration areas of CD206 to CD11c in
SCAT, ITA-PVAT, and CA-PVAT. Results are shown as meanSD. *P<0.05 vs SCAT; †P<0.05 vs ITA-PVAT.
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that it promotes the development of interstitial fibrosis.48 In
the present study, ITA-PVAT and CA-PVAT had significantly
greater extents of fibrosis with higher gene expression level of
MINCLE and smaller adipocyte size than did SCAT. As
previously reported,9 healthy adipose tissue expansion, which
is achieved in an anti-inflammatory state through enlargement
of preexisting adipocytes by lipid accumulation as adipocyte
hypertrophy, may occur in SCAT, whereas CA-PVAT and ITA-
PVAT harbor unhealthy pathological adipose tissue expansion
with fibrosis, which may result from higher gene expression
levels of metaflammation-related molecules, including
MINCLE. Similar to our results, it was previously reported
that a greater extent of fibrosis was observed in CA-PVAT than
in ITA-PVAT.49
Intravascular and organ infections were critical in the
preantibiotic era, and the presence of PVAT may have been
beneficial by ensuring a strong macrophage immune response
or by maintaining adipose tissue energy stores as part of the
thirfty phenotype to survive. Proinflammatory properties of
epicardial fat, including CA-PVAT, which is involved in
cardiovascular systems, especially the heart pumping blood
to organs, may have been crucial in controlling such infections
in the remote past. It has been reported that a short-term
high-fat diet upregulated proinflammatory gene expression in
PVAT of mice, suggesting that dietary lipids may be analogous
to bacterial membrane lipids, such as endotoxins, and activate
innate immune signaling pathways that lead to enhanced
vascular inflammation.31,50 It has also been reported that
Figure 4. Metaflammation and adipocyte developmental and pattern-forming factors in fat pads. A, Gene
expression levels of inflammatory molecules, including monocyte chemoattractant protein-1 (MCP-1),
interleukin-1b (IL-1b), interleukin-6 (IL-6), and tumor necrosis factor-a (TNFa), in subcutaneous adipose
tissue (SCAT) and in perivascular adipose tissue surrounding the internal thoracic artery (ITA-PVAT) and that
surrounding the coronary artery (CA-PVAT). B, Gene expression levels of M2-polarized state-related
molecules, including CD163, CD206, and interleukin-10 (IL-10), in SCAT, ITA-PVAT, and CA-PVAT. C, Gene
expression levels of adiponectin, inflammasome-related molecules, including nucleotide-binding domain,
leucine-rich–containing family, pyrin domain–containing-3 (NLRP3) and apoptosis-associated specklike
protein containing caspase recruitment domain (ASC), and endoplasmic reticulum stress-related molecules,
including glucose-regulated protein 78 (GRP78) and C/EBP homologous protein (CHOP), in SCAT, ITA-PVAT,
and CA-PVAT. D, Gene expression levels of adipocyte developmental and pattern-forming factors, including
engrailed homeobox 1 (EN1), empty spiracles homeobox 2 (EMX2), and homeobox A5 (HOXA5), in SCAT,
ITA-PVAT, and CA-PVAT (n=27 in each group). Results are shown as relative expression of each target gene
in SCAT of each patient and as meanSEM. AU indicates arbitrary unit. *P<0.05 vs SCAT; †P<0.05 vs ITA-
PVAT.
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metaflammation in adipose tissue promotes an angiogenic
response.50,51 As another potential significance of increased
metaflammation in CA-PVAT, inflammatory reaction derived
from CA-PVAT could be beneficial by the development of
collateral circulation in patients with obstructive CA disease.
This study has several limitations. First, the number of
patients was small, and there would have been selection bias
of patients. Second, because the recruited patients were only
Japanese people, it is unclear whether the present findings
can be generalized to other ethnicities. Third, because this
study was a cross-sectional study using patients with CA
disease, the study does not prove a causal relationship
between inflammatory changes in adipose tissue and the
development and progression of atherosclerosis. Finally, the
recruited patients had several diseases, including diabetes
mellitus, hypertension, and dyslipidemia, and had been
treated with several drugs, including angiotensin-converting
enzyme inhibitors, angiotensin receptor blockers, and statins.
At the basal point, mean body mass index was <25 kg/m2,
and mean systolic and diastolic blood pressures were within
normal ranges. Lifestyle-related diseases and administration
of drugs may have affected the extent of metaflammation and
fibrosis in adipose tissue.
In conclusion, the phenotype of ITA-PVAT is closer to that
of SCAT than that of CA-PVAT. The differential expression
pattern of adipocyte developmental and pattern-forming
genes in distinct adipose tissue may be a potential mecha-
nism underlying the difference in metaflammation in distinct
adipose tissue. CA-PVAT had a significantly larger extent of
CD11c-positive M1 macrophages, a lower ratio of CD206-
positive M2 to CD11c-positive M1 macrophages, higher gene
expression levels of several inflammatory cytokines, lower
gene expression levels of anti-inflammatory adipokines, more
activation of inflammasomes and endoplasmic reticulum
stress, and increased fibrosis than did ITA-PVAT and SCAT.
ITA-PVAT appears to be protected from pronounced metaflam-
mation and consecutive adipose tissue remodeling, which
may contribute to the decreased atherosclerotic plaque
burden in the ITA, an atherosclerosis-resistant vessel.
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